Evidence map›Paper›PMID 31672336›Full record

ArticleEBioMedicine2019

Chronicles of an FGF chimera: The odyssey continues.

Kyle H Flippo, Matthew J Potthoff

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. FGF-based drug discovery: advances and challenges.Nature reviews. Drug discovery · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kyle H FlippoDepartment of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States; Iowa Neurosciences Institute, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States.
Matthew J PotthoffDepartment of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States; Iowa Neurosciences Institute, University of Iowa Carver College of Medicine, 169 Newton Road, 3322 PBDB, Iowa City, IA 52242, United States; Department of Veterans Affairs Medical Center, Iowa City, IA 52242, United States. Electronic address: matthew-potthoff@uiowa.edu.

Funding

Regulation of Metabolism by FGF21R01DK106104 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Matthew Joseph Potthoff · 2015 to 2026
$6.2M
Diabetes Research Training Program Diversity SupplementT32DK112751 · NIDDK · UNIVERSITY OF IOWA · PI Andrew W Norris · 2017 to 2026
$4.8M
Fatty Acid Defects & Oxidative Stress Modulate Islet Function in Cystic FibrosisR01DK097820 · NIDDK · UNIVERSITY OF IOWA · PI NORRIS, ANDREW W, UC, ALIYE · 2012 to 2016
$1.9M
Central Mechanisms Regulating Macronutrient IntakeI01BX004634 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI Matthew Joseph Potthoff · 2019 to 2026
–
BLRD VA I01 BX004634NIDDK NIH HHS R01 DK097820NIDDK NIH HHS R01 DK106104NIDDK NIH HHS T32 DK112751
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fibroblast Growth Factor 1Fibroblast Growth FactorsHumansRecombinant Fusion ProteinsFibroblast Growth Factor 1fibroblast growth factor 21Fibroblast Growth FactorsRecombinant Fusion ProteinschimeraFGF1FGF21glucose

Identifiers

PMID31672336
PMCPMC6945278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.